BIRMINGHAM, England, Aug. 11, 2022 /PRNewswire/ Data Bridge Market research has recently published the comprehensive business research on "Global Smart Medical Devices Market" includes historic
CeQur, Medtronic, Roche, and Biocorp made moves in the diabetes market.
CeQur has raised $115 million in an oversubscribed equity financing. The Lucerne, Switzerland-based company has developed CeQur Simplicity, a wearable insulin delivery system.
Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem Diabetes Care, Ypsomed Group, Federated Hermes Kaufmann Funds, Kingdon Capital, and GMS Capital, as well as existing investors, Schroder & Co. Bank SA, and VI Partners.
Proceeds from the financing will be used to advance commercial plans for CeQur Simplicity, including market development activities, a phased commercial launch strategy that includes a limited market release in 2021, and the scale-up of high-volume manufacturing.
Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe